PCR20 Improvements in Symptoms, Impact of Treatment, and Satisfaction with Treatment Among Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Treated with Subcutaneous Epcoritamab
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1800
https://www.valueinhealthjournal.com/article/S1098-3015(23)01900-9/fulltext
Title :
PCR20 Improvements in Symptoms, Impact of Treatment, and Satisfaction with Treatment Among Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Treated with Subcutaneous Epcoritamab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01900-9&doi=10.1016/j.jval.2023.03.1800
First page :
Section Title :
Open access? :
No
Section Order :
11126